NVP-BSK805 TRIHYDROCHLORIDE

NVP-BSK805 TRIHYDROCHLORIDE

Biochem/physiol Actions

NVP-BSK805 is a selective, ATP-competitive (Ki = 0.43 nM) Janus kinase 2 (JAK2) inhibitor (IC50 = 0.58 and 0.56 nM against full-length wild-type and V617F JAK2, respectively) with greatly reduced potency against TYK2, JAK3, JAK1 (IC50 = 10.76, 18.68, 31.63 nM against respective JAK homology domain 1) and >300-fold selectivity over a panel of 36 other kinases. BSK805 potently inhibits STAT5 phosphorylation (by >90% at 100 nM; MB-02 & SET-2 cells) and proliferation in JAK2V617F mutant cultures in vitro (GI50= 39-331 nM; 75% SET-2 growth inhibition at 150 nM) and in Ba/F3 JAK2V617F-bearing mice in vivo (150 mg/kg p.o.). BSK805 daily oral administration is also efficacious against rhEpo-induced splenomegaly and polycythemia in mice (50-100 mg/kg) and rats (25-50 mg/kg) with good pharmacokinetics and oral avilability.

No detailed specifications are available for this product.

There are no downloads for this product.

Code Description Colour Manufacturer Storage Temp. Solubility Form Assay Price Quantity
3576605 NVP-BSK805 TRIHYDROCHLORIDE faint yellow to dark orange SIGMA-ALDRICH −20°C H2O: 2 mg/mL, clear
£483.32 (exc VAT) per EACH
-
+
3576606 NVP-BSK805 TRIHYDROCHLORIDE faint yellow to dark orange SIGMA-ALDRICH −20°C H2O: 2 mg/mL, clear
£119.93 (exc VAT) per EACH
-
+